Protara Therapeutics, Inc. beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.33 | $-0.36 | -9.1% | Miss |
| Q12026 FY2026 | $-0.36 | $-0.31 | +13.9% | Beat |
| Q42025 FY2025 | $-0.32 | $-0.37 | -15.6% | Miss |
Back to TARA overview · TARA holders · TARA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.